Cytokine expression during acute graft-versus-host disease after allogeneic peripheral stem cell transplantation
- PMID: 15852028
- DOI: 10.1038/sj.bmt.1704972
Cytokine expression during acute graft-versus-host disease after allogeneic peripheral stem cell transplantation
Abstract
Acute graft-versus-host disease (aGVHD) is one of the major problems following allogeneic peripheral blood stem cell transplantation (allo-PBSCT). In order to investigate the pathogenesis of human aGVHD, we analyzed cytokine gene expression and cytokine secretion by peripheral blood mononuclear cells (PBMC) in 30 patients who underwent allo-PBSCT. In this study, reverse transcription-polymerase chain reaction (RT-PCR) was used to explore the mRNA expression of interleukin (IL)-2, interferon (IFN)-gamma, IL-4, IL-10 and IL-12 in the PBMC of allo-PBSCT patients with aGVHD and in controls. The concentrations of these cytokines and of IL-18 were also measured by means of ELISA in medium obtained from cultured leukocytes after stimulation with PHA or LPS. Compared with the normal allo-PBSCT group (n=14), IL-2 and IFN-gamma were detected more frequently in aGVHD group (n=16). IL-12 and IL-18 were elevated, while IL-10 level decreased in the same group. There is no difference in IL-4 gene expression between patients with or without aGVHD, but the concentration of IL-4 for patients with grade II-IV aGVHD decreased. These data suggest that IL-2, IFN-gamma, IL-12 and IL-18 play important roles in the development of aGVHD in humans.
Similar articles
-
Cytokine gene expression by concanavalin A-stimulated peripheral mononuclear cells after bone marrow transplantation: an indicator of immunological abnormality due to chronic graft-versus-host disease.Bone Marrow Transplant. 1994 Nov;14(5):695-701. Bone Marrow Transplant. 1994. PMID: 7889002
-
Roles of interleukin-10 in acute graft-versus-host disease and graft rejection.Chin Med J (Engl). 2003 Apr;116(4):534-7. Chin Med J (Engl). 2003. PMID: 12875717
-
Cytokine gene expression in peripheral blood mononuclear cells and alloreactivity in hematopoietic cell transplantation with nonmyeloablative conditioning.Biol Blood Marrow Transplant. 2006 Jan;12(1):48-60. doi: 10.1016/j.bbmt.2005.09.002. Biol Blood Marrow Transplant. 2006. PMID: 16399568
-
Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.Dan Med Bull. 2007 May;54(2):112-39. Dan Med Bull. 2007. PMID: 17521527 Review.
-
Predicting outcome in hematological stem cell transplantation.Arch Immunol Ther Exp (Warsz). 2002;50(6):371-8. Arch Immunol Ther Exp (Warsz). 2002. PMID: 12546063 Review.
Cited by
-
Profiles of interferon-gamma and interleukin-2 in patients after allogeneic hematopoietic stem cell transplantation.World J Biol Chem. 2022 Sep 27;13(4):72-82. doi: 10.4331/wjbc.v13.i4.72. World J Biol Chem. 2022. PMID: 36187719 Free PMC article.
-
Human Wnt/β-Catenin Regulates Alloimmune Signaling during Allogeneic Transplantation.Cancers (Basel). 2021 Jul 28;13(15):3798. doi: 10.3390/cancers13153798. Cancers (Basel). 2021. PMID: 34359702 Free PMC article.
-
Targeting Interleukin-2-Inducible T-Cell Kinase (ITK) Differentiates GVL and GVHD in Allo-HSCT.Front Immunol. 2020 Nov 26;11:593863. doi: 10.3389/fimmu.2020.593863. eCollection 2020. Front Immunol. 2020. PMID: 33324410 Free PMC article.
-
The feasibility and efficacy of subcutaneous plerixafor for mobilization of peripheral blood stem cells in allogeneic HLA-identical sibling donors: results of the HOVON-107 study.Transfusion. 2019 Jan;59(1):316-324. doi: 10.1111/trf.15037. Epub 2018 Dec 11. Transfusion. 2019. PMID: 30548284 Free PMC article.
-
Nuclear factor-kappaB inducing kinase is required for graft-versus-host disease.Haematologica. 2010 Dec;95(12):2111-8. doi: 10.3324/haematol.2010.028829. Epub 2010 Sep 7. Haematologica. 2010. PMID: 20823135 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous